@article{Chamola_V-2022_92907,
title = {COVID-19 Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic},
author = {Chamola, V. and Mohammadi, R. and Nair, H. and Goyal, A. and Patel, A. and Hassija, V. and Bassetti, M. and Narang, P. and Paredes, R. and Santos, J. and Hashemi, S. and Sani, M. and Shirani, K. and Alijani, N. and Abtahi Naeini, B. and Pourazizi, M. and Abtahi, S. and Khorvash, F. and Khanjari, M. and Ahmadikia, K.},
month = {jul},
year = {2022},
abstract = {At a time when the COVID-19’s second wave is still picking up in countries like India, a number of reports describe the potential association with rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.},
volume = {27},
issue = {1},
journal = {Journal of Research in Medical Sciences},
publisher = {Wolters Kluwer},
url = {https://doi.org/10.4103/jrms.jrms_1090_21},
}
